| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 USP17L15 | 1.50e-15 | 114 | 135 | 15 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 USP17L15 | 5.44e-15 | 124 | 135 | 15 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 USP17L15 | 2.46e-14 | 137 | 135 | 15 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 USP17L15 | 3.59e-12 | 192 | 135 | 15 | GO:0008234 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 3.73e-08 | 15 | 135 | 5 | GO:0051011 | |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 MEP1A USP17L17 USP40 USP17L3 USP17L22 USP17L15 | 9.06e-06 | 654 | 135 | 16 | GO:0008233 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.57e-04 | 130 | 135 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 4.24e-04 | 22 | 135 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | LIMA1 ANK3 CLIP2 VEZT MYO9A SPTAN1 SPTB CEP290 NUMA1 TUBGCP2 CLIP1 CEP350 TLN1 SYNE2 MACF1 MYH15 UTRN NIN | 4.40e-04 | 1099 | 135 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | NAD+-protein-cysteine ADP-ribosyltransferase activity | 6.69e-04 | 6 | 135 | 2 | GO:0140803 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 8.75e-04 | 28 | 135 | 3 | GO:0003950 | |
| GeneOntologyMolecularFunction | actin filament binding | 9.05e-04 | 227 | 135 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1C1 ATP8B4 ABCA4 MYO9A ABCA13 ATAD5 MORC4 RAD50 DNAH17 MACF1 MYH15 ATP1B2 | 9.53e-04 | 614 | 135 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 1.07e-03 | 30 | 135 | 3 | GO:1990404 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.19e-03 | 308 | 135 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 1.97e-03 | 10 | 135 | 2 | GO:0140031 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 USP17L15 | 4.31e-15 | 125 | 136 | 15 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 USP17L15 | 3.65e-14 | 144 | 136 | 15 | GO:0070646 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 USP17L12 USP17L1 TRIM4 RPS6KA5 MYCBP2 USP17L20 USP17L11 USP17L24 USP17L5 NBN USP17L10 USP17L19 KIAA1586 USP17L18 PARP6 USP17L17 USP40 USP17L3 UBE2QL1 USP17L22 USP17L15 | 2.06e-06 | 1074 | 136 | 22 | GO:0043687 |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 3.70e-06 | 36 | 136 | 5 | GO:0035459 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 USP17L12 USP17L1 TRIM4 MYCBP2 USP17L20 USP17L11 USP17L24 USP17L5 NBN USP17L10 USP17L19 KIAA1586 USP17L18 USP17L17 USP40 USP17L3 UBE2QL1 USP17L22 USP17L15 | 1.03e-05 | 1009 | 136 | 20 | GO:0070647 |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | CTAGE9 ANK3 CTAGE6 RAB34 RABEP1 CTAGE8 TRAPPC10 CTAGE15 MACF1 CTAGE4 GOLGA4 | 1.57e-05 | 339 | 136 | 11 | GO:0048193 |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 ENKUR ANK3 CLIP2 CEP290 NUMA1 FYCO1 TUBGCP2 CLIP1 CEP350 DNAH17 SYNE2 SLC9B2 FER MACF1 CFAP69 INVS PCNT NIN | 6.69e-05 | 1058 | 136 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane transport | 9.93e-05 | 70 | 136 | 5 | GO:0006893 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CTAGE9 USP17L21 CALR3 DPY19L3 USP17L12 PTCHD3 USP17L1 USP17L20 USP17L11 ERO1A GRAMD1A USP17L5 USP17L10 CTAGE6 USP17L19 FADS2B USP17L18 PARP6 POM121 USP17L17 SYNE2 CTAGE8 USP17L3 CTAGE15 CTAGE4 USP17L22 USP17L15 | 9.04e-08 | 1299 | 138 | 27 | GO:0098827 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CTAGE9 USP17L21 CALR3 DPY19L3 USP17L12 PTCHD3 USP17L1 USP17L20 USP17L11 ERO1A GRAMD1A USP17L5 USP17L10 CTAGE6 USP17L19 FADS2B USP17L18 POM121 USP17L17 SYNE2 CTAGE8 USP17L3 CTAGE15 CTAGE4 USP17L22 USP17L15 | 3.10e-07 | 1293 | 138 | 26 | GO:0005789 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CTAGE9 USP17L21 CALR3 DPY19L3 USP17L12 PTCHD3 USP17L1 USP17L20 USP17L11 ERO1A GRAMD1A USP17L5 USP17L10 CTAGE6 USP17L19 FADS2B USP17L18 POM121 USP17L17 SYNE2 CTAGE8 USP17L3 CTAGE15 CTAGE4 USP17L22 USP17L15 | 5.10e-07 | 1327 | 138 | 26 | GO:0042175 |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 2.88e-06 | 133 | 138 | 8 | GO:0005881 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 8.15e-06 | 42 | 138 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | microtubule | ENKUR RPGRIP1L CLIP2 NUMA1 RIBC1 TUBGCP2 BOD1L2 CLIP1 DNAH17 MACF1 INVS PCNT NIN | 5.38e-05 | 533 | 138 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | cilium | ADCY10 ENKUR ABCA4 RPGRIP1L PTCHD3 CEP290 RIBC1 EVC TBC1D31 RAB34 DNAH17 SLC9B2 CABCOCO1 CFAP69 INVS PCNT NIN | 9.06e-05 | 898 | 138 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | supramolecular fiber | ENKUR EPPK1 RPGRIP1L ANK3 CLIP2 MYO9A SPTAN1 NUMA1 RIBC1 TUBGCP2 BOD1L2 CLIP1 DNAH17 SYNE2 MACF1 MYH15 MYOM2 INVS PCNT NIN | 9.51e-05 | 1179 | 138 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | ENKUR EPPK1 RPGRIP1L ANK3 CLIP2 MYO9A SPTAN1 NUMA1 RIBC1 TUBGCP2 BOD1L2 CLIP1 DNAH17 SYNE2 MACF1 MYH15 MYOM2 INVS PCNT NIN | 1.04e-04 | 1187 | 138 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule organizing center | RPGRIP1L CEP290 NUMA1 EVC TUBGCP2 ECPAS BOD1L2 HNMT CLIP1 CEP350 TBC1D31 RAB34 CEP112 CAPRIN2 CABCOCO1 PCNT NIN | 1.20e-04 | 919 | 138 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | RPGRIP1L CEP290 NUMA1 TUBGCP2 ECPAS BOD1L2 HNMT CLIP1 CEP350 TBC1D31 CEP112 CAPRIN2 CABCOCO1 PCNT NIN | 1.77e-04 | 770 | 138 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | Mre11 complex | 4.27e-04 | 5 | 138 | 2 | GO:0030870 | |
| GeneOntologyCellularComponent | cell projection membrane | 5.93e-04 | 431 | 138 | 10 | GO:0031253 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 6.38e-04 | 6 | 138 | 2 | GO:0070533 | |
| GeneOntologyCellularComponent | microtubule plus-end | 8.17e-04 | 28 | 138 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | ENKUR EPPK1 RPGRIP1L CLIP2 MYO9A NUMA1 RIBC1 TUBGCP2 BOD1L2 CLIP1 DNAH17 MACF1 INVS PCNT NIN | 8.94e-04 | 899 | 138 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.51e-03 | 9 | 138 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 1.51e-03 | 9 | 138 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | microtubule end | 2.01e-03 | 38 | 138 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | motile cilium | 2.51e-03 | 355 | 138 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | astrocyte end-foot | 2.73e-03 | 12 | 138 | 2 | GO:0097450 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.74e-03 | 210 | 138 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 3.00e-03 | 90 | 138 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | sperm flagellum | 3.01e-03 | 214 | 138 | 6 | GO:0036126 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 4.68e-21 | 16 | 129 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 4.68e-21 | 16 | 129 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 | 1.56e-17 | 66 | 129 | 14 | IPR018200 |
| Domain | UCH | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 | 4.71e-17 | 71 | 129 | 14 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 | 4.71e-17 | 71 | 129 | 14 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 | 5.81e-17 | 72 | 129 | 14 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 | 5.81e-17 | 72 | 129 | 14 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 | 5.81e-17 | 72 | 129 | 14 | IPR001394 |
| Domain | USP_1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP40 USP17L3 USP17L22 | 1.49e-15 | 70 | 129 | 13 | PS00972 |
| Domain | Spectrin | 4.43e-07 | 23 | 129 | 5 | PF00435 | |
| Domain | Spectrin_repeat | 1.51e-06 | 29 | 129 | 5 | IPR002017 | |
| Domain | SPEC | 2.52e-06 | 32 | 129 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.52e-06 | 32 | 129 | 5 | IPR018159 | |
| Domain | ACTININ_2 | 1.74e-05 | 23 | 129 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.74e-05 | 23 | 129 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.74e-05 | 23 | 129 | 4 | IPR001589 | |
| Domain | CAP_GLY | 3.73e-05 | 10 | 129 | 3 | PF01302 | |
| Domain | CAP_GLY | 3.73e-05 | 10 | 129 | 3 | SM01052 | |
| Domain | - | 3.73e-05 | 10 | 129 | 3 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 3.73e-05 | 10 | 129 | 3 | PS00845 | |
| Domain | CAP_GLY_2 | 3.73e-05 | 10 | 129 | 3 | PS50245 | |
| Domain | CAP-Gly_domain | 3.73e-05 | 10 | 129 | 3 | IPR000938 | |
| Domain | WGR_domain | 5.86e-04 | 24 | 129 | 3 | IPR008893 | |
| Domain | - | 6.97e-04 | 6 | 129 | 2 | 3.90.1290.10 | |
| Domain | Plectin | 9.72e-04 | 7 | 129 | 2 | PF00681 | |
| Domain | Plectin_repeat | 9.72e-04 | 7 | 129 | 2 | IPR001101 | |
| Domain | PLEC | 9.72e-04 | 7 | 129 | 2 | SM00250 | |
| Domain | CH | 1.06e-03 | 65 | 129 | 4 | SM00033 | |
| Domain | CH | 1.40e-03 | 70 | 129 | 4 | PF00307 | |
| Domain | - | 1.48e-03 | 71 | 129 | 4 | 1.10.418.10 | |
| Domain | CH | 1.64e-03 | 73 | 129 | 4 | PS50021 | |
| Domain | CH-domain | 1.81e-03 | 75 | 129 | 4 | IPR001715 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.71e-18 | 45 | 99 | 13 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.21e-10 | 221 | 99 | 14 | M27578 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 SPTAN1 SPTB USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 TLN1 USP17L3 USP17L22 USP17L15 | 6.43e-10 | 318 | 99 | 16 | MM15278 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.70e-10 | 191 | 99 | 13 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L1 TRIM4 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.42e-09 | 299 | 99 | 15 | M27574 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 3.50e-08 | 262 | 99 | 13 | MM15286 |
| Pathway | WP_JOUBERT_SYNDROME | 1.51e-05 | 76 | 99 | 6 | M39835 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L12 ANK3 USP17L1 TRIM4 USP17L20 USP17L11 SPTAN1 SPTB USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 ST6GAL2 POM121 RAB34 ART3 USP17L17 USP17L3 TRAPPC10 PRKDC USP17L22 USP17L15 GOLGB1 | 2.17e-05 | 1475 | 99 | 25 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | CTAGE9 USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 SPTAN1 SPTB USP17L5 USP17L10 USP17L19 USP17L18 ST6GAL2 POM121 RAB34 ART3 USP17L17 CTAGE8 USP17L3 TRAPPC10 PRKDC USP17L22 USP17L15 GOLGB1 | 2.42e-05 | 1389 | 99 | 24 | MM15307 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.39e-27 | 21 | 139 | 13 | 8622927 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.39e-27 | 21 | 139 | 13 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.39e-27 | 21 | 139 | 13 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.39e-27 | 21 | 139 | 13 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.39e-27 | 21 | 139 | 13 | 12447969 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.39e-27 | 21 | 139 | 13 | 18980247 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.80e-26 | 22 | 139 | 13 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.97e-26 | 24 | 139 | 13 | 8995226 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.04e-25 | 33 | 139 | 14 | 20228807 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 20403174 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 17109758 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 19188362 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 11941478 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 10936051 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.76e-25 | 34 | 139 | 14 | 21448158 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.86e-25 | 25 | 139 | 13 | 21115691 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.92e-25 | 35 | 139 | 14 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.92e-25 | 35 | 139 | 14 | 21239494 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 3.71e-25 | 26 | 139 | 13 | 35816173 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.77e-25 | 36 | 139 | 14 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.64e-25 | 37 | 139 | 14 | 20228808 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.40e-24 | 29 | 139 | 13 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.17e-20 | 50 | 139 | 13 | 31806660 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | ADCY10 EPPK1 MYO9A ABCA13 FYCO1 CLIP1 RAD50 CEP112 TLN1 CAPRIN2 FAR1 GOLGB1 | 5.22e-11 | 208 | 139 | 12 | 33230847 |
| Pubmed | CYLC2 LIMA1 ZNF658 SPTAN1 TAF1B NUMA1 CTAGE6 PCF11 NOP14 TBC1D31 CEP112 SNX25 ARHGAP12 SYNE2 CTAGE8 CAPRIN2 CTAGE15 MACF1 MYH15 MYOM2 PRKDC CTAGE4 CFAP69 GOLGB1 PCNT | 5.83e-10 | 1442 | 139 | 25 | 35575683 | |
| Pubmed | ARMT1 RPGRIP1L ANK3 MYCBP2 VEZT ATAD5 SPTAN1 GRAMD1A CEP290 NBN CEP350 PCF11 NUDT12 NOP14 TBC1D31 SMG7 SYNE2 UTRN GOLGA4 PCNT NIN | 1.33e-09 | 1049 | 139 | 21 | 27880917 | |
| Pubmed | LIMA1 ERO1A SPTAN1 SPTB NUMA1 RABEP1 TLN1 MACF1 PRKDC UTRN GOLGA4 GOLGB1 PCNT | 2.54e-09 | 360 | 139 | 13 | 33111431 | |
| Pubmed | SUPT20H MYCBP2 ATAD5 SPTAN1 PARG CEP290 NBN ARHGAP11A WTAP RAD50 CEP350 TBC1D31 TLN1 UTRN PCNT NIN | 7.49e-09 | 645 | 139 | 16 | 25281560 | |
| Pubmed | RPGRIP1L CEP290 TUBGCP2 CLIP1 CEP350 TBC1D31 CEP112 PCNT NIN | 8.14e-09 | 146 | 139 | 9 | 21399614 | |
| Pubmed | EPPK1 MYCBP2 SPTAN1 TUT7 NUMA1 FRYL ECPAS RAD50 NOP14 TLN1 SYNE2 MACF1 SCAF11 PRKDC UTRN PCNT | 8.90e-09 | 653 | 139 | 16 | 22586326 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ANK3 MYCBP2 VEZT TSHZ2 MYO9A SPTB EVC FRYL ECPAS ZNF248 ZNF33A ZNF33B SMG7 RABEP1 USP40 MACF1 SCAF11 CFAP69 UTRN GOLGA4 GOLGB1 INVS PCNT | 2.65e-08 | 1489 | 139 | 23 | 28611215 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L20 USP17L11 RIBC1 USP17L19 USP17L18 USP17L17 | 2.87e-08 | 119 | 139 | 8 | 28625976 |
| Pubmed | SUPT20H ANK3 RPS6KA5 CLIP2 MYO9A SPTAN1 CEP290 CEP350 POM121 HPS4 MACF1 PRKDC GOLGB1 | 8.70e-08 | 486 | 139 | 13 | 20936779 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LIMA1 RPS6KA5 MYCBP2 SPTAN1 PARG NUMA1 NBN ECPAS CLIP1 WTAP RAD50 PCF11 TRAPPC10 SCAF11 PRKDC GOLGA4 | 9.25e-08 | 774 | 139 | 16 | 15302935 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 RIBC1 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 UBE2QL1 USP17L22 USP17L15 | 9.32e-08 | 674 | 139 | 15 | 37196079 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RPGRIP1L SUPT20H MYO9A NBN ZDBF2 TUBGCP2 MORC4 RAD50 SMG7 RABEP1 MACF1 GOLGB1 PCNT NIN | 1.13e-07 | 588 | 139 | 14 | 38580884 |
| Pubmed | 1.87e-07 | 210 | 139 | 9 | 16565220 | ||
| Pubmed | LIMA1 DOCK8 SPTAN1 FRYL TUBGCP2 ECPAS CLIP1 RABEP1 TRAPPC10 PRKDC UTRN NIN | 2.62e-07 | 446 | 139 | 12 | 24255178 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RPGRIP1L TUT7 CEP290 RIBC1 NBN TUBGCP2 ECPAS CLIP1 RAD50 CEP350 TBC1D31 SMG7 TLN1 ARHGAP12 PCNT NIN | 3.41e-07 | 853 | 139 | 16 | 28718761 |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 3.73e-07 | 37 | 139 | 5 | 27565344 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 24220101 | ||
| Pubmed | 6.35e-07 | 76 | 139 | 6 | 27542412 | ||
| Pubmed | 8.34e-07 | 251 | 139 | 9 | 29778605 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.37e-06 | 197 | 139 | 8 | 20811636 | |
| Pubmed | Inhibition of hsp90 compromises the DNA damage response to radiation. | 2.16e-06 | 7 | 139 | 3 | 16982765 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TRIM4 MYCBP2 ERO1A TUT7 CEP290 FYCO1 TUBGCP2 ECPAS RAD50 CEP350 CEP112 GOLGB1 PCNT NIN | 2.17e-06 | 754 | 139 | 14 | 33060197 |
| Pubmed | LIMA1 ANK3 TRIM4 MYCBP2 SPTAN1 NUMA1 NBN RAD50 SMG7 RABEP1 TLN1 PRKDC | 2.30e-06 | 549 | 139 | 12 | 38280479 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | LIMA1 EPPK1 RPGRIP1L SPTAN1 CEP290 FYCO1 RABEP1 PRKDC FAR1 GOLGA4 GOLGB1 INVS | 3.04e-06 | 564 | 139 | 12 | 21565611 |
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 15456891 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | LIMA1 EPPK1 MYCBP2 CEP290 NUMA1 RAD50 CEP350 POM121 TLN1 SYNE2 MACF1 PRKDC FAR1 UTRN GOLGB1 PCNT | 3.64e-06 | 1024 | 139 | 16 | 24711643 |
| Pubmed | 3.69e-06 | 225 | 139 | 8 | 12168954 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 DOCK8 SPTAN1 NBN TUBGCP2 RAD50 PCF11 TLN1 MACF1 PRKDC GOLGB1 PCNT | 4.18e-06 | 582 | 139 | 12 | 20467437 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYCBP2 ATAD5 SPTAN1 TAF1B NBN CPED1 NECAP1 CEP350 RAB34 SMG7 TLN1 FER MACF1 | 7.30e-06 | 724 | 139 | 13 | 36232890 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 7.34e-06 | 10 | 139 | 3 | 22159418 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 7.34e-06 | 10 | 139 | 3 | 24207026 | |
| Pubmed | 7.59e-06 | 418 | 139 | 10 | 34709266 | ||
| Pubmed | LIMA1 ANK3 CLIP2 MYCBP2 SPTAN1 NUMA1 FYCO1 CLIP1 RAD50 RABEP1 SYNE2 MACF1 GOLGA4 GOLGB1 PCNT | 7.76e-06 | 963 | 139 | 15 | 28671696 | |
| Pubmed | ANK3 MYCBP2 VEZT ATAD5 ERO1A SPTAN1 GRAMD1A NBN PCF11 NOP14 TBC1D31 TLN1 SYNE2 MACF1 FAR1 GOLGA4 GOLGB1 PCNT NIN | 7.79e-06 | 1487 | 139 | 19 | 33957083 | |
| Pubmed | RPGRIP1L MYCBP2 VEZT ERO1A TUT7 CEP290 NBN ZDBF2 TUBGCP2 CEP350 NUDT12 TBC1D31 GOLGA4 | 8.33e-06 | 733 | 139 | 13 | 34672954 | |
| Pubmed | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. | 1.01e-05 | 11 | 139 | 3 | 15758953 | |
| Pubmed | 1.01e-05 | 11 | 139 | 3 | 19270065 | ||
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 1.03e-05 | 34 | 139 | 4 | 25925205 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.21e-05 | 190 | 139 | 7 | 15161933 | |
| Pubmed | 1.34e-05 | 12 | 139 | 3 | 24695638 | ||
| Pubmed | MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining. | 1.34e-05 | 12 | 139 | 3 | 30017584 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 33625872 | ||
| Pubmed | Role of gamma delta T cells in the inflammatory response of experimental colitis mice. | 1.59e-05 | 2 | 139 | 2 | 14607957 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15265687 | ||
| Pubmed | History-dependent catastrophes regulate axonal microtubule behavior. | 1.59e-05 | 2 | 139 | 2 | 20471267 | |
| Pubmed | RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. | 1.59e-05 | 2 | 139 | 2 | 16474176 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24193021 | ||
| Pubmed | NuMA1 promotes axon initial segment assembly through inhibition of endocytosis. | 1.59e-05 | 2 | 139 | 2 | 31727776 | |
| Pubmed | Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex. | 1.59e-05 | 2 | 139 | 2 | 16622404 | |
| Pubmed | Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis. | 1.59e-05 | 2 | 139 | 2 | 30054381 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19640199 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9890967 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 19904603 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 21811815 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.59e-05 | 361 | 139 | 9 | 26167880 | |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 1.74e-05 | 13 | 139 | 3 | 17920017 | |
| Pubmed | 2.05e-05 | 285 | 139 | 8 | 32838362 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 2.20e-05 | 14 | 139 | 3 | 11793228 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ARMT1 EPPK1 ANK3 TRIM4 MYCBP2 SPTAN1 NUMA1 FYCO1 ECPAS TLN1 MACF1 PRKDC UTRN | 2.28e-05 | 807 | 139 | 13 | 30575818 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | LIMA1 ATAD5 PARG NUMA1 NBN RAD50 SMG7 RABEP1 TLN1 MACF1 PRKDC UTRN GOLGB1 PCNT | 2.42e-05 | 934 | 139 | 14 | 33916271 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 2.82e-05 | 298 | 139 | 8 | 32353859 | |
| Pubmed | 3.34e-05 | 497 | 139 | 10 | 23414517 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | LIMA1 MYCBP2 MYO9A SPTAN1 FRYL CEP350 CEP112 RABEP1 SYNE2 MACF1 UTRN GOLGA4 GOLGB1 | 4.44e-05 | 861 | 139 | 13 | 36931259 |
| Pubmed | 4.52e-05 | 159 | 139 | 6 | 30581152 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 33090711 | ||
| Pubmed | Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. | 4.75e-05 | 3 | 139 | 2 | 12124328 | |
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 11062235 | ||
| Pubmed | 4.75e-05 | 3 | 139 | 2 | 14684699 | ||
| Pubmed | Single-Molecule Imaging Reveals How Mre11-Rad50-Nbs1 Initiates DNA Break Repair. | 4.75e-05 | 3 | 139 | 2 | 28867292 | |
| Pubmed | Haplotypic variation in MRE11, RAD50 and NBS1 and risk of non-Hodgkin's lymphoma. | 4.75e-05 | 3 | 139 | 2 | 17169801 | |
| Interaction | CEP152 interactions | RPGRIP1L ANK3 MYO9A TUBGCP2 ECPAS TIPARP CEP350 SMG7 PCNT NIN | 3.12e-07 | 179 | 133 | 10 | int:CEP152 |
| Interaction | CTAGE1 interactions | 3.69e-07 | 10 | 133 | 4 | int:CTAGE1 | |
| Interaction | KCNA3 interactions | ADCY10 EPPK1 ANK3 MYO9A ABCA13 NUMA1 FYCO1 ECPAS CLIP1 RAD50 CEP112 TLN1 ARHGAP12 CAPRIN2 MACF1 PRKDC FAR1 GOLGA4 GOLGB1 | 4.52e-06 | 871 | 133 | 19 | int:KCNA3 |
| Interaction | FLT3 interactions | USP17L21 EPPK1 USP17L12 USP17L20 USP17L11 RIBC1 USP17L19 ECPAS USP17L18 USP17L17 PRKDC | 8.67e-06 | 318 | 133 | 11 | int:FLT3 |
| Interaction | TMOD1 interactions | 1.17e-05 | 161 | 133 | 8 | int:TMOD1 | |
| Interaction | ATOH1 interactions | 1.49e-05 | 80 | 133 | 6 | int:ATOH1 | |
| Interaction | ARHGAP21 interactions | 1.76e-05 | 223 | 133 | 9 | int:ARHGAP21 | |
| Interaction | PHF21A interactions | MYCBP2 ZDBF2 MORC4 ECPAS TIPARP RAD50 RABEP1 FAR1 UTRN GOLGB1 PCNT | 1.76e-05 | 343 | 133 | 11 | int:PHF21A |
| Interaction | PCM1 interactions | RPGRIP1L MYCBP2 MYO9A CEP290 ECPAS TIPARP CEP350 TBC1D31 SMG7 CEP112 PCNT NIN | 3.13e-05 | 434 | 133 | 12 | int:PCM1 |
| Interaction | PCNT interactions | 3.24e-05 | 241 | 133 | 9 | int:PCNT | |
| Interaction | SIRT7 interactions | EPPK1 MYCBP2 SPTAN1 TUT7 NUMA1 FRYL ECPAS RAD50 NOP14 TLN1 SYNE2 MACF1 SCAF11 PRKDC UTRN PCNT | 3.25e-05 | 744 | 133 | 16 | int:SIRT7 |
| Interaction | MAPRE1 interactions | LIMA1 CLIP2 VEZT SPTAN1 CEP290 NUMA1 CLIP1 TIPARP CEP350 TBC1D31 MACF1 PCNT NIN | 3.65e-05 | 514 | 133 | 13 | int:MAPRE1 |
| Interaction | VPS33B interactions | 5.36e-05 | 199 | 133 | 8 | int:VPS33B | |
| Interaction | CEP135 interactions | 8.25e-05 | 272 | 133 | 9 | int:CEP135 | |
| Interaction | OFD1 interactions | RPGRIP1L CEP290 NBN RAD50 CEP350 TBC1D31 SMG7 RABEP1 PCNT NIN | 1.04e-04 | 347 | 133 | 10 | int:OFD1 |
| Interaction | WWTR1 interactions | LIMA1 ANK3 TRIM4 MYCBP2 SPTAN1 NUMA1 NBN RAD50 SMG7 RABEP1 TLN1 | 1.14e-04 | 422 | 133 | 11 | int:WWTR1 |
| Interaction | RPGRIP1L interactions | 1.26e-04 | 225 | 133 | 8 | int:RPGRIP1L | |
| Interaction | BORCS6 interactions | 1.37e-04 | 170 | 133 | 7 | int:BORCS6 | |
| Interaction | PFN1 interactions | MYO9A DOCK8 SPTAN1 NBN CEP350 SMG7 RABEP1 SYNE2 MACF1 GOLGA4 GOLGB1 PCNT | 1.43e-04 | 509 | 133 | 12 | int:PFN1 |
| Interaction | KDM1A interactions | RPGRIP1L TRIM4 MYCBP2 FYCO1 ZDBF2 MORC4 ECPAS TIPARP RAD50 CEP350 SMG7 RABEP1 FAR1 UTRN GOLGB1 PCNT NIN | 1.55e-04 | 941 | 133 | 17 | int:KDM1A |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 | 1.57e-17 | 79 | 139 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 EVC USP17L10 USP17L19 USP17L18 NOP14 USP17L17 USP17L22 USP17L15 | 8.69e-15 | 222 | 139 | 14 | chr4p16 |
| Cytoband | 7q35 | 2.43e-05 | 55 | 139 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 5.01e-05 | 66 | 139 | 4 | chr7q35 | |
| Cytoband | 10p11.2 | 2.52e-04 | 8 | 139 | 2 | 10p11.2 | |
| Cytoband | 8p23.3 | 8.09e-04 | 14 | 139 | 2 | 8p23.3 | |
| GeneFamily | CTAGE family | 3.12e-09 | 15 | 75 | 5 | 907 | |
| GeneFamily | BRCA1 C complex|MRN complex | 5.08e-05 | 3 | 75 | 2 | 1344 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.68e-04 | 5 | 75 | 2 | 1336 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.52e-04 | 7 | 75 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.68e-04 | 8 | 75 | 2 | 939 | |
| GeneFamily | ATP binding cassette subfamily A | 1.50e-03 | 14 | 75 | 2 | 805 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.22e-03 | 17 | 75 | 2 | 684 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.42e-16 | 86 | 138 | 13 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 ERO1A USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 9.93e-16 | 112 | 138 | 14 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L12 ANK3 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CAPRIN2 USP17L3 USP17L22 USP17L15 | 7.13e-15 | 160 | 138 | 15 | MM1155 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ARMT1 LIMA1 MYCBP2 MYO9A TAF1B TUT7 CEP290 NBN ARHGAP11A CLIP1 RAD50 TDRD7 CEP350 NUDT12 CEP112 RABEP1 SYNE2 CAPRIN2 FER SCAF11 GOLGA4 GOLGB1 NIN | 6.16e-13 | 656 | 138 | 23 | M18979 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 SUPT20H USP17L12 USP17L1 RPS6KA5 USP17L20 USP17L11 NUMA1 USP17L5 USP17L10 USP17L19 ECPAS ARHGAP11A CLIP1 TIPARP USP17L18 SMG7 USP17L17 ARHGAP12 USP17L3 USP17L22 USP17L15 | 4.59e-08 | 1072 | 138 | 22 | MM1031 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 MORC4 USP17L18 POM121 USP17L17 USP17L3 USP17L22 UTRN USP17L15 | 3.26e-07 | 647 | 138 | 16 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 ATP6V1C1 USP17L12 USP17L1 USP17L20 USP17L11 TUT7 PARG USP17L5 USP17L10 USP17L19 MORC4 TIPARP USP17L18 POM121 USP17L17 CEP112 CAPRIN2 USP17L3 USP17L22 UTRN USP17L15 | 4.61e-07 | 1226 | 138 | 22 | MM979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SUPT20H MYCBP2 PARG NBN FRYL ARHGAP11A CLIP1 TIPARP TDRD7 CEP350 PCF11 TBC1D31 ARHGAP12 SYNE2 MACF1 GOLGA4 IL7R PCNT | 6.12e-07 | 856 | 138 | 18 | M4500 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 ATP6V1C1 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 NBN USP17L10 USP17L19 CLIP1 WTAP USP17L18 USP17L17 RABEP1 TLN1 FER USP17L3 USP17L22 USP17L15 | 4.83e-06 | 1198 | 138 | 20 | MM1062 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 6.35e-06 | 86 | 138 | 6 | M39248 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 PARG NBN FRYL CLIP1 TIPARP TDRD7 CEP350 ARHGAP12 GOLGA4 IL7R | 3.78e-05 | 466 | 138 | 11 | M13522 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.87e-05 | 180 | 138 | 7 | M8239 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP | 9.16e-05 | 199 | 138 | 7 | M7766 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 9.16e-05 | 199 | 138 | 7 | M5893 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 9.45e-05 | 200 | 138 | 7 | M331 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 9.45e-05 | 200 | 138 | 7 | M7505 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SAMD9 RPS6KA5 MYCBP2 DOCK8 SPTAN1 GRAMD1A NUMA1 FRYL SLFN5 CLIP1 CEP350 PCF11 GVINP1 TLN1 TRAPPC10 MACF1 SCAF11 UTRN IL7R NIN | 1.09e-04 | 1492 | 138 | 20 | M40023 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.26e-07 | 85 | 123 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ATAD5 SPTAN1 PARG CEP290 ZDBF2 ECPAS PCF11 NOP14 POM121 SMG7 RABEP1 SCAF11 PRKDC PCNT | 2.56e-06 | 532 | 123 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 2.59e-06 | 38 | 123 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.10e-06 | 45 | 123 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.64e-05 | 192 | 123 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RPGRIP1L SWT1 MYO9A ATAD5 TUT7 CEP290 NUMA1 ZDBF2 CLIP1 ZNF248 RAD50 RABEP1 SYNE2 PRKDC CFAP69 GOLGA4 | 2.48e-05 | 831 | 123 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.38e-05 | 110 | 123 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SAMD9 MYCBP2 DOCK8 FRYL SLFN5 CEP350 SYNE2 RASGEF1B MACF1 SCAF11 UTRN GOLGA4 GOLGB1 | 3.62e-14 | 200 | 132 | 13 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 DOCK8 PARG SLFN5 CLIP1 CEP350 TLN1 MACF1 SCAF11 UTRN GOLGA4 IL7R | 3.47e-13 | 184 | 132 | 12 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | ANK3 TSHZ2 SPTAN1 GRAMD1A LRRK1 NMNAT3 SYNE2 MACF1 UTRN GOLGB1 IL7R NIN | 5.08e-13 | 190 | 132 | 12 | 91ba66d4b56c59523485b17738e93f14bb00afa4 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | MYCBP2 CEP290 SLFN5 RAD50 CEP350 RABEP1 SYNE2 SCAF11 UTRN GOLGA4 GOLGB1 | 1.97e-11 | 198 | 132 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 CLIP1 TIPARP PCF11 NOP14 SYNE2 SCAF11 FAR1 GOLGA4 GOLGB1 | 2.43e-10 | 187 | 132 | 10 | 663991a8afe652e92363b64bcbd68c14d0307f0e |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | SAMD9 CEP290 SLFN5 CLIP1 RAD50 CEP350 SYNE2 CABCOCO1 GOLGA4 GOLGB1 | 4.46e-10 | 199 | 132 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | LIMA1 CEP290 SLFN5 CLIP1 RAD50 CEP350 SYNE2 UTRN GOLGA4 GOLGB1 | 4.46e-10 | 199 | 132 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-09 | 176 | 132 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.85e-09 | 197 | 132 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.58e-09 | 199 | 132 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-08 | 182 | 132 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 8.37e-08 | 185 | 132 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-08 | 185 | 132 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.73e-08 | 186 | 132 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.47e-08 | 188 | 132 | 8 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-07 | 190 | 132 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-07 | 193 | 132 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.47e-07 | 199 | 132 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.52e-07 | 200 | 132 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-06 | 177 | 132 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-06 | 177 | 132 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 177 | 132 | 7 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.01e-06 | 177 | 132 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-06 | 177 | 132 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-06 | 177 | 132 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 187 | 132 | 7 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-06 | 188 | 132 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-06 | 188 | 132 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-06 | 188 | 132 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.56e-06 | 189 | 132 | 7 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 1.68e-06 | 191 | 132 | 7 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.68e-06 | 191 | 132 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.92e-06 | 195 | 132 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 195 | 132 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.13e-06 | 198 | 132 | 7 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.20e-06 | 199 | 132 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.20e-06 | 199 | 132 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.20e-06 | 199 | 132 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.20e-06 | 199 | 132 | 7 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 2.20e-06 | 199 | 132 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.20e-06 | 199 | 132 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 200 | 132 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.28e-06 | 200 | 132 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.28e-06 | 200 | 132 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.28e-06 | 200 | 132 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.52e-06 | 130 | 132 | 6 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.52e-06 | 130 | 132 | 6 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 4.20e-06 | 142 | 132 | 6 | 319812c84fad93276bf093f2ad78db02ae745bf4 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 1.03e-05 | 166 | 132 | 6 | ff32422390852546e0cb216192452e9c47bd9509 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 168 | 132 | 6 | 97bf074b91c9ae0064edc31fa4a2658ffdcfefa3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 170 | 132 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-05 | 171 | 132 | 6 | e1fe07652c10c37191d1471ddaea500f74269e0c | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.26e-05 | 172 | 132 | 6 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 176 | 132 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 178 | 132 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-05 | 181 | 132 | 6 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.68e-05 | 181 | 132 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 182 | 132 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 182 | 132 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.79e-05 | 183 | 132 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-05 | 184 | 132 | 6 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 132 | 6 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 2.08e-05 | 188 | 132 | 6 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-05 | 189 | 132 | 6 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-05 | 189 | 132 | 6 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 190 | 132 | 6 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 190 | 132 | 6 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 191 | 132 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 191 | 132 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 191 | 132 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-05 | 192 | 132 | 6 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.41e-05 | 193 | 132 | 6 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.41e-05 | 193 | 132 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 2.41e-05 | 193 | 132 | 6 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.41e-05 | 193 | 132 | 6 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.41e-05 | 193 | 132 | 6 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.41e-05 | 193 | 132 | 6 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 194 | 132 | 6 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.55e-05 | 195 | 132 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 195 | 132 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-05 | 196 | 132 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.70e-05 | 197 | 132 | 6 | c842d169dfce9af3ed7c01dc7e940c0bdd21388c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 197 | 132 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.70e-05 | 197 | 132 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.78e-05 | 198 | 132 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.78e-05 | 198 | 132 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.78e-05 | 198 | 132 | 6 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.78e-05 | 198 | 132 | 6 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.78e-05 | 198 | 132 | 6 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-05 | 198 | 132 | 6 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.78e-05 | 198 | 132 | 6 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 2.78e-05 | 198 | 132 | 6 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 2.78e-05 | 198 | 132 | 6 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.86e-05 | 199 | 132 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.86e-05 | 199 | 132 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.86e-05 | 199 | 132 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.74e-08 | 49 | 74 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.33e-08 | 50 | 74 | 7 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.47e-04 | 49 | 74 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Neighborhood of BMPR2 | 4.70e-04 | 53 | 74 | 4 | MORF_BMPR2 | |
| Drug | Clorgyline | SAMD9 TUT7 CEP290 CLIP1 RAD50 CEP350 SCAF11 UTRN GOLGA4 GOLGB1 | 2.48e-08 | 168 | 122 | 10 | ctd:D003010 |
| Drug | semustine; Down 200; 100uM; PC3; HT_HG-U133A | 1.01e-05 | 194 | 122 | 8 | 7492_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 5425_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 6994_UP | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.50e-22 | 46 | 133 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.86e-20 | 69 | 133 | 14 | DOID:1682 (implicated_via_orthology) |
| Disease | Congenital cataract | 2.99e-04 | 6 | 133 | 2 | C0009691 | |
| Disease | X-16935 measurement | 4.17e-04 | 7 | 133 | 2 | EFO_0800763 | |
| Disease | influenza A (H1N1) | 6.57e-04 | 87 | 133 | 4 | EFO_1001488 | |
| Disease | Nephronophthisis | 7.11e-04 | 9 | 133 | 2 | cv:C0687120 | |
| Disease | 6-bromotryptophan measurement | 7.11e-04 | 9 | 133 | 2 | EFO_0800099 | |
| Disease | ciliopathy (implicated_via_orthology) | 7.83e-04 | 40 | 133 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 8.86e-04 | 10 | 133 | 2 | cv:C0265215 | |
| Disease | brain infarction (implicated_via_orthology) | 1.08e-03 | 11 | 133 | 2 | DOID:3454 (implicated_via_orthology) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.29e-03 | 12 | 133 | 2 | C0403553 | |
| Disease | Ciliopathies | 1.57e-03 | 110 | 133 | 4 | C4277690 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.77e-03 | 14 | 133 | 2 | C0677776 | |
| Disease | urate measurement, bone density | 2.02e-03 | 619 | 133 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Meckel-Gruber syndrome | 2.04e-03 | 15 | 133 | 2 | C0265215 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.62e-03 | 17 | 133 | 2 | OBA_2045173 | |
| Disease | 4-ethylphenylsulfate measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0021148 | |
| Disease | Meckel syndrome type 1 | 2.94e-03 | 18 | 133 | 2 | C3714506 | |
| Disease | Phenyllactate (PLA) measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0021662 | |
| Disease | colorectal cancer, inflammatory bowel disease | 3.28e-03 | 19 | 133 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | Severe Combined Immunodeficiency | 3.63e-03 | 20 | 133 | 2 | C0085110 | |
| Disease | Familial aplasia of the vermis | 3.63e-03 | 20 | 133 | 2 | cv:C0431399 | |
| Disease | Down syndrome (is_marker_for) | 4.39e-03 | 22 | 133 | 2 | DOID:14250 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEEWHKFIQLLTEFQ | 1486 | Q96QE3 | |
| DFNWLIEQVKHSNHK | 296 | Q9H993 | |
| THSQKSEDWNIFDVK | 46 | Q8IVU9 | |
| TSHKQLFQQEAEVWK | 221 | Q8IX94 | |
| TSHKQLFQQEAEVWK | 221 | Q86UF2 | |
| TSHKQLFQQEAEVWK | 221 | P0CG41 | |
| TSHKQLFQQEAEVWK | 221 | A4FU28 | |
| TSHKQLFQQEAEVWK | 221 | A4D2H0 | |
| QDWEKHFLDASTSKQ | 226 | Q96L12 | |
| NETLQEWQKVHGTKF | 791 | A4D0V7 | |
| LKHLETEDNIKVWFN | 1606 | P78363 | |
| EHQQSSEAQDKSKLW | 891 | Q58F21 | |
| ADNFVSTHLDKQEWN | 76 | Q8IYS8 | |
| LSEEELHEKFNQLWK | 1881 | Q7Z2Y8 | |
| QSTESLNNDWEKKLH | 346 | Q8N8E3 | |
| TSANDFKWFELNQLK | 471 | Q86UQ4 | |
| DNWKSKLDSLASDHQ | 611 | Q9UDT6 | |
| SELSKKSWNQQHFAL | 21 | Q14093 | |
| SWKDSKHSLNNEKII | 216 | Q8TF62 | |
| ATLHENDLWFSNIKE | 66 | Q6ZPD9 | |
| ESEEKTNRTWNNLFK | 756 | Q96PN6 | |
| TEWAEILALQKQFHS | 661 | Q96CP6 | |
| HAQWQKEGNDKDFTL | 241 | Q01581 | |
| EHTKQWLADALKEND | 141 | Q9BZG1 | |
| LEDWLHSKSKEINQT | 576 | Q92878 | |
| LKHTWQKANDQFLES | 276 | Q15276 | |
| SETEWNLLQKEVHNA | 511 | Q15276 | |
| QKWQSVFNDSQEHLE | 276 | Q7Z3E1 | |
| NKDVKDAFWKLIHTQ | 296 | Q8NGL3 | |
| DDQHFAKQDWTLLKQ | 1176 | Q9UPP5 | |
| VQFIWKKHLFEDSQN | 416 | Q17RR3 | |
| EDKKTFNIDVRQLHW | 416 | Q8WVX9 | |
| HKDLWASKNENEEIL | 461 | Q9UHB6 | |
| SAAHEEQWKLKEQQL | 371 | Q68CZ1 | |
| VFWKNHLKDVDFSEN | 446 | Q38SD2 | |
| LESLKHQQDALWTEK | 616 | Q13439 | |
| LWQKSDALEFQQKLS | 1151 | Q9BQS8 | |
| ESWDQHVQKLNKFLE | 101 | P14415 | |
| SDLHKIFNSLWNLDQ | 151 | Q9NQG7 | |
| DLELKSKQSLIDWNN | 281 | Q5VYK3 | |
| SNLENVKFAWHKETS | 106 | P50135 | |
| KSTKVFHENQLAIWN | 771 | Q9HCI6 | |
| KWQNEGKHTEQLLES | 156 | Q86W56 | |
| WLDNILDSLDKKVHQ | 1136 | O94915 | |
| WHILEKNLKSASNID | 706 | Q9BSJ2 | |
| QEKDENKWTHVNLSS | 171 | P16871 | |
| EIKEHLFFQKINWDD | 311 | O75582 | |
| LDQDWKEIQTLLSHK | 221 | P78316 | |
| HVNFEKFWELAKQVS | 396 | Q0VAM2 | |
| DFEEQLWKKDSLHQT | 996 | O95613 | |
| HKEANSVLQWLESKE | 4471 | Q9UPN3 | |
| AVNHDEKLDLNDSKW | 706 | Q8IWW6 | |
| HKNSQLVKDFQELWS | 141 | A8MWK0 | |
| WEENKSLQQVDEHSK | 601 | O94913 | |
| KASLQWFNQALEDKS | 541 | Q96HA1 | |
| KNLDELLATHKNLSW | 431 | Q8IYK2 | |
| EQTHWRQANEKLDKT | 1401 | Q8NF50 | |
| AHFLKEVTSWQQKLS | 1466 | Q9UFH2 | |
| QADSSLNKFKQTAWD | 1591 | O15078 | |
| DLKNSHEAVLKLQDW | 6 | P16591 | |
| HEQKNTKEKDLSWSE | 2351 | Q5VT06 | |
| ETWKEHQFDSKNEDL | 1086 | Q12955 | |
| KSWENNVESQKHSLT | 546 | Q6IMN6 | |
| KKNWEEVHKEFQSLS | 201 | Q8TC29 | |
| EETQKAVLQWTKHDD | 146 | Q96HE7 | |
| RQKEELLTQQHKAFW | 416 | P57679 | |
| TKDKLEQAQNELSAW | 131 | Q15007 | |
| HKQRELANKSWEDFL | 826 | A5D8W1 | |
| KLKESHWEENRNENS | 1041 | Q99590 | |
| HANKENSDVIALWKS | 611 | P30622 | |
| DVQSKQWLTHLLDQF | 336 | Q3KNS1 | |
| HLENDKNNISWLKED | 16 | A0A1B0GVS7 | |
| WLKEDTQLTNAKHAD | 26 | A0A1B0GVS7 | |
| EEHSKATQEWLEKQA | 346 | Q14980 | |
| QWKHLSNDFLKTQQE | 141 | Q2NL67 | |
| SNDFLKTQQEKRHSW | 146 | Q2NL67 | |
| EVDTQDKNKQTALHW | 141 | Q9Y283 | |
| SDEHNDVQKKTFTKW | 26 | P46939 | |
| KLNHNDWIKQYETLA | 191 | P21283 | |
| KVSDHIQWFNKLSLN | 806 | Q6P4F7 | |
| TDWQIQSLHKQKCDD | 896 | Q96DN5 | |
| KWFLKQEINAAVEHA | 971 | Q96DN5 | |
| NLKIKWENLSNHVTD | 2576 | Q8WXH0 | |
| LEEQWLSLNKKIDHE | 4921 | Q8WXH0 | |
| EIDDKLNKINDRWQH | 5991 | Q8WXH0 | |
| EQKSWEHQSASLKSQ | 1746 | Q8N4C6 | |
| LWSAKEISNNDKLQD | 631 | O60934 | |
| FWESVEHLKNANKNE | 316 | Q9H3E2 | |
| KEDVNQWLESHKIDQ | 16 | Q5K651 | |
| FEWSLSNLAEKHNEK | 376 | Q53T94 | |
| ADWKQKHEESQALLD | 1466 | Q9Y2K3 | |
| ATAEIQDWAKEKQHT | 451 | Q14916 | |
| ALDKKVEQDLWNHAF | 51 | Q92540 | |
| LIEKQETSNKHLWFQ | 2161 | P58107 | |
| KVQTFQGDDDHNWKI | 376 | Q16819 | |
| LEQERNHWQSEFKKV | 796 | Q8TE76 | |
| VINDNVQIKHKWSSS | 161 | Q86UD5 | |
| LQKWAQSQDGFEHKE | 96 | Q96JF0 | |
| VHENLNSWIELKKFS | 2086 | O75592 | |
| EKRNNSDWLLAKESH | 131 | Q9BQG2 | |
| ITNADLWKHQKDVFL | 836 | Q8NHU6 | |
| HFINDSLKNQDRKLW | 451 | Q5T5J6 | |
| HSKAQEDAWKQILAF | 391 | Q8N9L9 | |
| ESTLDHWKFLQEQNK | 431 | A6NCW0 | |
| DWNVKLHQVDKDSVL | 26 | A1L167 | |
| KIFSDWLSFNQHKEI | 146 | Q8TC21 | |
| LKERSQENQSKHLWE | 91 | Q06732 | |
| LVKSTEFNEHELKQW | 16 | P62760 | |
| KQAHRQAEKTLDTEW | 296 | Q8N443 | |
| LKQKLHTDDELNWLD | 161 | Q9Y490 | |
| AQFVEHWKELKQLAA | 1846 | Q13813 | |
| KHSELEKQDNSWKET | 886 | O94964 | |
| TSDNHKWTQEDKLLL | 181 | Q8NEM7 | |
| ESTLDHWKFLQEQNK | 431 | D6R9N7 | |
| ESTLDHWKFLQEQNK | 431 | A8MUK1 | |
| QEEKHLVFNKTAFWE | 341 | Q9HCK1 | |
| ESTLDHWKFLQEQNK | 431 | D6R901 | |
| ESTLDHWKFLQEQNK | 431 | D6RCP7 | |
| WDELQATTKEKTQHL | 1361 | P11277 | |
| ESTLDHWKFLQEQNK | 431 | Q7RTZ2 | |
| SNKSDFDWHQDALSK | 161 | Q9NRE2 | |
| LIHWFTNNKKFESQD | 991 | P78527 | |
| KERSQENQSKHLWEV | 91 | Q06730 | |
| KKDQHWKFQTLEESF | 201 | Q5TYW1 | |
| ESTLDHWKFLQEQNK | 431 | C9JPN9 | |
| ESTLDHWKFLQEQNK | 431 | Q0WX57 | |
| DDLTKWQNVLKAHSS | 106 | P48553 | |
| EAERQKWKQLLFSDH | 596 | Q9HBM0 | |
| HLQDVEVKNATQWKD | 176 | Q9C037 | |
| FLKEDNSWENNTLSH | 316 | Q86XD8 | |
| NDSHKDQSKRWLSDE | 91 | Q5VYS8 | |
| ESTLDHWKFLQEQNK | 431 | D6RA61 | |
| ESTLDHWKFLQEQNK | 431 | C9J2P7 | |
| ESTLDHWKFLQEQNK | 431 | D6RBQ6 | |
| KDVDHLGNWQFQEEK | 311 | Q9NVE5 | |
| LKDISVKENNLEEHW | 391 | Q8NA31 | |
| KENHFLIFVKSWNTE | 91 | Q08AF3 | |
| WELLFHNNKTVSVEN | 101 | Q8NDW4 | |
| ESTLDHWKFLQEQNK | 431 | D6RJB6 | |
| ESTLDHWKFLQEQNK | 431 | C9JJH3 | |
| SQWKDQNIEDHFEKP | 131 | Q96BR6 | |
| ESTLDHWKFLQEQNK | 431 | C9JVI0 | |
| RLEHDKQIWESKAQT | 2256 | Q14789 | |
| LKEEKASHQQLDTVW | 56 | Q13508 | |
| NQKLEDHSEKNWKLE | 286 | Q13508 | |
| NWKLEDHGEKNQKLE | 296 | Q13508 | |
| ALNEKNQHDTFDIAW | 786 | B2RTY4 | |
| VIWFKNDQDIQLSEH | 1376 | P54296 | |
| VSLQDHFKWVKQESE | 121 | Q8NC96 | |
| NLWKDAHIQEIVEKF | 146 | Q96T66 |